Modified reconstituted basement membrane composition for assay system
View Patent ↗A modified reconstituted extracellular matrix composition is provided herein. The composition includes an extracellular matrix and at least one exogenous component selected from heparin, fibronectin and laminin. The composition may have a basic pH. Additionally, provided herein is a cell culturing system including a substrate and a coating thereon of the composition to assess potential stimulators and/or inhibitors for their effects on various cell cultures while increasing the signal dynamic range.
1. A composition for coating a surface comprising:
(a) a growth factor reduced extracellular matrix extracted from Engelbreth-Holm-Swarm mouse sarcoma tumor;
(b) fibronectin which is exogenous to said growth factor reduced extracellular matrix; and
(c) heparin which is exogenous to said growth factor reduced extracellular matrix; wherein endothelial cell tube formation in the composition is minimal in the absence of an exogenous stimulator.
2. The composition of claim 1 , wherein the growth factor reduced extracellular matrix comprises laminin.
3. The composition of claim 1 , wherein the composition has a basic pH.
4. The composition of claim 3 , wherein the pH of the composition is between about 7.8 to about 8.5.
5. The composition of claim 1 , further comprising a Tris buffer at a concentration sufficient to buffer in the basic pH range.
6. The composition of claim 5 , wherein the Tris buffer is present at a concentration of about 0.01 M to about 0.05 M.
7. The composition of claim 1 , further comprising sodium chloride.
8. The composition of claim 7 , wherein the sodium chloride is present at a concentration of about 0.03 M to about 0.15 M.
9. The composition of claim 1 , wherein the growth factor reduced extracellular matrix is present at a concentration of about 10 mg/mL of the composition.
10. The composition of claim 1 , wherein the fibronectin which is exogenous to the growth factor reduced extracellular matrix is present at a concentration of about 5 μg/ml to about 20 μg/ml of the composition.
11. The composition of claim 1 , wherein the heparin which is exogenous to said growth factor reduced extracellular matrix is present at a concentration of about 200 μg/ml to about 800 μg/ml of the composition.
12. The composition of claim 1 , wherein endothelial cell tube formation in the composition is insignificant in the absence of an exogenous stimulator.
13. The composition of claim 1 , wherein the growth factor reduced extracellular matrix is solubilized.
14. The composition of claim 1 , wherein the growth factor reduced extracellular matrix is polymerized.
15. The composition of claim 14 , wherein the composition is polymerized by incubating the composition at a temperature from about 22° C. to about 37° C. for a period of time of about 30 minutes to about 4 hours to allow polymerization thereof.
16. The composition of claim 14 , wherein the growth factor reduced extracellular matrix is a reconstituted extracellular matrix.
17. The composition of claim 16 , wherein the reconstituted extracellular matrix comprises the fibronectin which is exogenous to said growth factor reduced extracellular matrix and the is heparin which is exogenous to said growth factor reduced extracellular matrix therethroughout.
18. An extracellular matrix composition for coating a surface comprising:
(a) a growth factor reduced extracellular matrix extracted from Engelbreth-Holm-Swarm mouse sarcoma tumor;
(b) fibronectin which is exogenous to the growth factor reduced extracellular matrix; and
(c) heparin which is exogenous to the growth factor reduced extracellular matrix;
the extracellular matrix composition having a basic pH; and
wherein the growth factor reduced extracellular matrix is present at a concentration of about 10 mg/mL of the composition, the fibronectin which is exogenous to the growth factor reduced extracellular matrix is present at a concentration of about 5 μg /mL to about 20 μg/mL of the composition, and the heparin which is exogenous to the growth factor reduced extracellular matrix is present at a concentration of about 200 μg/mL to about 800 μg/mL of the composition.
19. A cell culturing system comprising:
a substrate; and
a polymerized coating formed on the substrate from a coating composition comprising:
(a) a growth factor reduced extracellular matrix extracted from Engelbreth-Holm-Swarm mouse sarcoma tumor;
(b) fibronectin which is exogenous to said growth factor reduced extracellular matrix; and
(c) heparin which is exogenous to said growth factor reduced extracellular matrix;
wherein the polymerized coating is formed on the substrate by incubating the coating composition with the substrate at a temperature from about 22° C. to about 37° C. for about 30 minutes to about 4 hours;
wherein said polymerized coating includes therethroughout said exogenous components; and
wherein endothelial cell tube formation in the polymerized coating is minimal in the absence of an exogenous stimulator.
20. The system of claim 19 , wherein the coating composition has a basic pH.
21. The system of claim 19 , wherein the substrate is selected from the group consisting of cellulose membranes, porous polycarbonate, porous polytetrafluoroethylene, nylon membranes, glass filters, porous polyethyleneterephthalate, polymethylpentane, polypropylene, polyethylene and combinations thereof.
22. The system of claim 19 , wherein endothelial cell tube formation in the polymerized coating is insignificant in the absence of an exogenous stimulator.